Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity

Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity

We sought to analyze the evolutionary characteristics and neutralization sensitivity of viruses in a human immunodeficiency virus type 1 (HIV-1) subtype B′ infected plasma donor with broadly neutralizing activity, which may provide information for new broadly neutralizing antibodies (bNAbs) isolatio...

Full description

Bibliographic Details
Main Authors:	Yuanyuan Hu, Sen Zou, Zheng Wang, Ying Liu, Li Ren, Yanling Hao, Shasha Sun, Xintao Hu, Yuhua Ruan, Liying Ma, Yiming Shao, Kunxue Hong
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Vaccines
Subjects:	HIV-1 envelope gene recombination broadly neutralizing activity neutralizing antibodies
Online Access:	https://www.mdpi.com/2076-393X/9/4/311

Similar Items

Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
by: Dai Zhang, et al.
Published: (2019-05-01)

Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies
by: Maya Contreras, et al.
Published: (2024-02-01)

Cross-reactive broadly neutralizing antibodies: timing is everything
by: Zelda eEuler, et al.
Published: (2012-07-01)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
by: Matthew S. Parsons, et al.
Published: (2018-08-01)

Impact of HIV-1 Diversity on Its Sensitivity to Neutralization
by: Karl Stefic, et al.
Published: (2019-07-01)

Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent
by: Blandine Noailly, et al.
Published: (2022-06-01)

Neutralization Sensitivity and Evolution of Virus in a Chronic HIV-1 Clade B Infected Patient with Neutralizing Activity against Membrane-Proximal External Region
by: Wenqi Tang, et al.
Published: (2023-03-01)

The Mechanism of bnAb Production and Its Application in Mutable Virus Broad-Spectrum Vaccines: Inspiration from HIV-1 Broad Neutralization Research
by: Xinyu Zhang, et al.
Published: (2023-06-01)

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
by: Narayanaiah Cheedarla, et al.
Published: (2018-03-01)

Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1
by: Elisabeth Narayanan, et al.
Published: (2022-10-01)

The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses
by: Eirini Moysi, et al.
Published: (2018-08-01)

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
by: Yubin Liu, et al.
Published: (2020-01-01)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
by: Hursch Patel, et al.
Published: (2023-09-01)

Contribution of rare mutational outcomes to broadly neutralizing antibodies
by: Feng Anqi, et al.
Published: (2022-06-01)

Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies
by: Victor Ovchinnikov, et al.
Published: (2018-02-01)

Highly mutated antibodies capable of neutralizing N276 glycan-deficient HIV after a single immunization with an Env trimer
by: Jeong Hyun Lee, et al.
Published: (2022-03-01)

The Ability of Porcine Reproductive and Respiratory Syndrome Virus Isolates to Induce Broadly Reactive Neutralizing Antibodies Correlates With In Vivo Protection
by: Francisco Javier Martínez-Lobo, et al.
Published: (2021-07-01)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01)

A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target
by: Emma Parker Miller, et al.
Published: (2021-09-01)

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
by: Zhigang Zhang, et al.
Published: (2021-03-01)

Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies
by: Xiaojun Li, et al.
Published: (2022-11-01)

Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4+ T cells measures viral sensitivity to broadly neutralizing antibodies
by: Dmitriy Mazurov, et al.
Published: (2024-01-01)

Double and Triple Combinations of Broadly Neutralizing Antibodies Provide Efficient Neutralization of All HIV-1 Strains from the Global Panel
by: Evgeniya A. Kochina, et al.
Published: (2022-08-01)

Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?
by: Matthew J. Burke, et al.
Published: (2020-04-01)

A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains
by: Hebang Yao, et al.
Published: (2023-12-01)

Elicitation of broadly neutralizing antibodies against HIV-1 – the germline/maturation hypothesis
by: Prabakaran ePonraj, et al.
Published: (2014-08-01)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
by: Sabari Nath Neerukonda, et al.
Published: (2020-07-01)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
by: Prashant Bajpai, et al.
Published: (2022-06-01)

Recombinant Full-Length Hepatitis C Virus E1E2 Dimer Elicits Pangenotypic Neutralizing Antibodies
by: Tianli Lin, et al.
Published: (2022-06-01)

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
by: Colin LaMont, et al.
Published: (2022-07-01)

Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users
by: Zelda EULER, et al.
Published: (2019-04-01)

In Silico Analysis of Neutralizing Antibody Epitopes on The Hepatitis C Virus Surface Glycoproteins
by: Raziyeh Zareh-Khoshchehreh, et al.
Published: (2023-01-01)

Levels of neutralizing antibodies against resident farm strain or vaccine strain are not indicators of protection against PRRSV-1 vertical transmission under farm conditions
by: Gerard Eduard Martin-Valls, et al.
Published: (2023-10-01)

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
by: Zhiyin An, et al.
Published: (2023-05-01)

Primary HIV-1 and Infectious Molecular Clones Are Differentially Susceptible to Broadly Neutralizing Antibodies
by: Jiae Kim, et al.
Published: (2020-12-01)

Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?
by: Denise C. Hsu, et al.
Published: (2021-07-01)

Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies against HIV-1
by: Lei eYu, et al.
Published: (2014-06-01)

Functional development of a V3/glycan-specific broadly neutralizing antibody isolated from a case of HIV superinfection
by: Mackenzie M Shipley, et al.
Published: (2021-07-01)

A New Method to Monitor the Primary Neutral Integrity in Multi-Grounded Neutral Systems
by: Xiangmin Xie, et al.
Published: (2017-03-01)